ACAT · CIK 0001781726
NP Life Sciences Health Industry Group Inc.
Annual figures as reported, FY2018–FY2023. Ratios and growth rates derived on-page.
Services-Educational Services
Company profile
Revenue
$165K
▲ +61.4% vs FY2022
Net income
−$3K
▲ +84.4% vs FY2022
Operating cash flow
−$74K
▼ −178.4% vs FY2022
Diluted EPS
$0.00
Revenue
Annual, as reported
Net income
Losses shown in terracotta
Recent quarters
momentum · last 12 quartersRevenue — Dec ’23 quarter
$10K
Net income — Dec ’23 quarter
−$38K
▼ −327.0% vs Dec ’22
Revenue — trailing 12 months
$165K
Diluted EPS — trailing 12 months
$0.00
Quarterly revenue
Discrete quarters; Q4 derived from the annual figure
Quarterly net income
Losses shown in terracotta
| Quarter | Revenue | Rev. YoY | Gross margin | Net income | Net margin | Diluted EPS |
|---|---|---|---|---|---|---|
| Dec ’23 | $10K | — | — | −$38K | −376.6% | — |
| Sep ’23 | $18K | −57.3% | — | −$38K | −215.1% | — |
| Jun ’23 | $107K | 614.9% | — | $71K | 66.5% | — |
| Mar ’23 | $30K | — | — | $1K | 4.1% | $0.00 |
| Sep ’22 | $41K | — | — | −$5K | −13.3% | — |
| Jun ’22 | $15K | — | — | $1K | 7.2% | — |
| Jun ’20 | $0 | −100.0% | — | — | — | $0.00 |
| Mar ’20 | $15K | −25.0% | — | — | — | $0.00 |
Profitability & returns
quality of earningsMargins
Share of revenue kept at each line
Operating marginNet margin
Returns on capital
Net income vs year-end equity and assets
Return on equityReturn on assets
Cash flow
cash generationOperating cash flow
Net cash from operations
Shareholder returns
capital allocationDiluted shares outstanding
Falling count means buybacks outpace dilution
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Growth rates
compounding, annualizedRevenue CAGR
+122.2%
3y
Key ratios
derived per fiscal year| Fiscal year | Op. margin | Net margin | ROE | ROA |
|---|---|---|---|---|
| FY2023 | −0.4% | −1.8% | −17.9% | −3.8% |
| FY2022 | −18.5% | −18.5% | −97.6% | −14.8% |
| FY2021 | −187.7% | −187.7% | −172.1% | −171.0% |
| FY2020 | −873.9% | −873.8% | −126.2% | −110.5% |
| FY2019 | −253.2% | −253.1% | −46.3% | −43.5% |
| FY2018 | — | — | — | — |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2023 | $165K | — | −$690 | −$3K | $0.00 | −$74K | — | $77K | $60K | $16K | $71K | — |
| FY2022 | $102K | — | −$19K | −$19K | $0.00 | $94K | — | $128K | $108K | $19K | $122K | — |
| FY2021 | $35K | — | −$66K | −$66K | $0.00 | −$91K | — | $38K | $239 | $38K | $28K | — |
| FY2020 | $15K | — | −$131K | −$131K | $0.00 | −$124K | — | $119K | $15K | $104K | $119K | — |
| FY2019 | $43K | — | −$109K | −$109K | $0.00 | −$4K | — | $250K | $15K | $235K | $243K | — |
| FY2018 | — | — | — | — | — | — | — | $200 | $21K | −$21K | $200 | — |
Latest filings
the most recent regulatory filings15-12GSEC filing2024-08-21 ↗15-12GSEC filing2024-05-15 ↗10-KAnnual report2024-04-16 ↗NT 10-KSEC filing2024-04-02 ↗10-QQuarterly report2023-11-14 ↗10-QQuarterly report2023-08-14 ↗10-QQuarterly report2023-05-15 ↗10-KAnnual report2023-04-18 ↗NT 10-KSEC filing2023-04-03 ↗DEF 14CSEC filing2022-11-30 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.